Skip to main content
AKBA logo

AKBA · Akebia Therapeutics, Inc.

$0.90 -0.05 (-5.53%)
Market Cap
$264.47M
Shares
277.11M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-07-14 1,638 $1.38 $2,260
2026-07-13 1,638 $1.40 $2,293
2026-07-10 2,782 $1.43 $3,978
2026-07-09 1,638 $1.42 $2,326
2026-07-08 1,638 $1.36 $2,228
2026-07-07 1,638 $1.30 $2,129
2026-07-06 1,638 $1.24 $2,031
2026-07-02 2,067 $1.21 $2,501
2026-07-01 9,523 $1.14 $10,856
2026-06-30 148,814 $1.11 $165,184
2026-06-29 1,638 $1.14 $1,867
2026-06-26 1,638 $1.04 $1,704
2026-06-25 1,638 $1.06 $1,736
2026-06-24 1,638 $1.10 $1,802
2026-06-23 1,638 $1.09 $1,785
2026-06-22 147,176 $1.07 $157,478
2026-06-18 37,552 $1.02 $38,303
2026-06-17 1,638 $0.98 $1,605
2026-06-15 11 $0.92 $10
2026-06-08 53,353 $0.94 $50,152
2026-05-11 29,120 $1.16 $33,779
Showing 1–21 of 21 settlements
Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 53 filings 53 filers Visit website Investor relations